The company has teamed up with Thermo Fisher Scientific, a world-renowned organization dedicated to improving and simplifying life science research. The collaboration has resulted in the development of a fully automated thermal cycler, the ideal system for integration into liquid handling and robotics systems for improved efficiency.
The thermal cycler has been developed as a powerful standard PCR system, available in 96 well or 384 well format. It is equipped with a patented, motorized plate-lifter system, allowing for the automatic changing of plates after PCR runs, as well as trouble-free processes.
The thermal cycler presents a significant advancement of technology and has been designed to meet the ever-growing demands of the molecular diagnostics industry. Guangdong Hecin Scientific, Inc. has always been at the forefront of innovation, specializing in the development of in-vitro diagnostics (IVD). The company has a wealth of expertise and knowledge in this sector, making it ideally placed to become one of the first companies to implement the new Thermo Fisher Scientific technology.
Furthermore, Guangdong Hecin Scientific, Inc. has developed the largest database of respiratory pathogens in China. This impressive feat provides the company with an exceptional level of expertise when it comes to tackling respiratory diseases. The company has a 5,000 m² GMP factory and a biosafety level II laboratory of respiratory pathogens, ensuring that every product, from the design phase to the manufacturing process, complies with international standards.
The development of the fully automated thermal cycler will revolutionize the PCR process, providing a powerful tool for researchers and medical professionals alike. The system’s advanced features allow for highly reliable, high-throughput PCR analysis, removing manual tasks and reducing the probability of human error.
This revolutionary PCR system will have a significant impact on the development of IVD in both public health and clinical settings. It will provide medical professionals with quick, accurate and reliable results and will enable them to diagnose respiratory diseases promptly. The automated system also increases efficiency, reducing costs and enabling researchers to study respiratory diseases with greater precision.
According to Guangdong Hecin Scientific, Inc., the partnership with Thermo Fisher Scientific is just the beginning of the company’s ambitious plans for the future. The company aims to continue to provide innovative solutions for the IVD industry, meeting the ever-growing demand for reliable and accurately diagnosed respiratory diseases.
The fully automated thermal cycler is just one example of the company’s vision for the future of medical diagnostics. According to a spokesperson for Guangdong Hecin Scientific, Inc., “The company believes the future of diagnostics will include more advanced technologies, faster test results, and the ability to detect diseases before they spread. We are committed to developing innovative solutions for the diagnosis and treatment of respiratory diseases and look forward to continuing our work in this vital field.”
The Thermo Fisher Scientific partnership highlights the company’s drive towards innovation, their dedication to providing accurate diagnoses and their commitment to furthering medical research in the field of respiratory diseases.